Source:http://linkedlifedata.com/resource/pubmed/id/12440610
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-20
|
pubmed:abstractText |
Viable cardiomyocytes after myocardial infarction (MI) are unable to repair the necrotic myocardium due to their limited capability of regeneration. The present study investigated whether intramyocardial transplantation of human mesenchymal stem cells (hMSCs) or cotransplantation of hMSCs plus human fetal cardiomyocytes (hFCs; 1:1) reconstituted impaired myocardium and improved cardiac function in MI pigs.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1568-75
|
pubmed:dateRevised |
2007-11-15
|
pubmed:articleTitle |
Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs.
|
pubmed:affiliation |
Stem Cell Research Laboratory, The Charles A. Dana Research Institute, Boston, Massachusetts, USA.
|